Immunovant Inc (IMVT)
30.51
+1.23
(+4.20%)
USD |
NASDAQ |
Oct 04, 16:00
30.56
+0.05
(+0.16%)
After-Hours: 20:00
Immunovant Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
Date | Value |
---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median